Literature DB >> 9794803

Increased bioactivation of dihaloalkanes in rat liver due to induction of class theta glutathione S-transferase T1-1.

P J Sherratt1, M M Manson, A M Thomson, E A Hissink, G E Neal, P J van Bladeren, T Green, J D Hayes.   

Abstract

A characteristic feature of the class Theta glutathione S-transferase (GST) T1-1 is its ability to activate dichloromethane and dibromoethane by catalysing the formation of mutagenic conjugates. The level of the GSTT1 subunit within tissues is an important determinant of susceptibility to the carcinogenic effects of these dihaloalkanes. In the present study it is demonstrated that hepatic GST activity towards these compounds can be elevated significantly in female and male Fischer-344 rats by feeding these animals on diets supplemented with cancer chemopreventive agents. Immunoblotting experiments showed that increased activity towards the dihaloalkanes is associated with elevated levels of the GSTT1 subunit in rat liver. Sex-specific effects were observed in the induction of GSTT1 protein. Amongst the chemopreventive agents tested, indole-3-carbinol proved to be the most potent inducer of hepatic GSTT1 in male rats (6.2-fold), whereas coumarin was the most potent inducer of this subunit in the livers of female rats (3. 5-fold). Phenobarbital showed significant induction of GSTT1 only in male rat liver and had little effect in female rat liver. Western blotting showed that class Alpha, Mu and Pi GST subunits are not co-ordinately induced with GSTT1, indicating that the expression of GSTT1 is determined, at least in part, by mechanisms distinct from those that regulate levels of other transferases. The increase in amount of hepatic GSTT1 protein was also reflected by an increase in the steady-state level of mRNA in response to treatment with chemopreventive agents and model inducers. Immunohistochemical detection of GSTT1 in rat liver supported the Western blotting data, but showed, in addition to cytoplasmic staining, significant nuclear localization of the enzyme in hepatocytes from some treated animals, including those fed on an oltipraz-containing diet. Significantly, the hepatic level of cytochrome P-450 2E1, an enzyme which offers a detoxification pathway for dihaloalkanes, was unchanged by the various inducing agents studied. It is concluded that the induction of GSTT1 by dietary components and its localization within cells are important factors that should be considered when assessing the risk dihaloalkanes pose to human health.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794803      PMCID: PMC1219824          DOI: 10.1042/bj3350619

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

1.  Tissue distribution of enzymic methylation of glutathione S-transferase and its effects on catalytic activity. Methylation of glutathione S-transferase 11-11 inhibits conjugating activity towards 1-chloro-2,4-dinitrobenzene.

Authors:  J A Johnson; K A Finn; F L Siegel
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

2.  Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and II drug metabolizing enzymes and aflatoxin B1 metabolism.

Authors:  M M Manson; H W Ball; M C Barrett; H L Clark; D J Judah; G Williamson; G E Neal
Journal:  Carcinogenesis       Date:  1997-09       Impact factor: 4.944

3.  The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity.

Authors:  T H Rushmore; M R Morton; C B Pickett
Journal:  J Biol Chem       Date:  1991-06-25       Impact factor: 5.157

4.  Evidence that human class Theta glutathione S-transferase T1-1 can catalyse the activation of dichloromethane, a liver and lung carcinogen in the mouse. Comparison of the tissue distribution of GST T1-1 with that of classes Alpha, Mu and Pi GST in human.

Authors:  P J Sherratt; D J Pulford; D J Harrison; T Green; J D Hayes
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

5.  Human Mu-class glutathione S-transferases present in liver, skeletal muscle and testicular tissue.

Authors:  A J Hussey; J D Hayes
Journal:  Biochim Biophys Acta       Date:  1993-11-10

6.  Quantitation of tissue- and sex-specific induction of rat GSH transferase subunits by dietary 1,2-dithiole-3-thiones.

Authors:  D J Meyer; J M Harris; K S Gilmore; B Coles; T W Kensler; B Ketterer
Journal:  Carcinogenesis       Date:  1993-04       Impact factor: 4.944

Review 7.  Glutathione-associated enzymes in anticancer drug resistance.

Authors:  K D Tew
Journal:  Cancer Res       Date:  1994-08-15       Impact factor: 12.701

8.  Chemical and molecular regulation of enzymes that detoxify carcinogens.

Authors:  T Prestera; W D Holtzclaw; Y Zhang; P Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

9.  Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation.

Authors:  P H Jellinck; P G Forkert; D S Riddick; A B Okey; J J Michnovicz; H L Bradlow
Journal:  Biochem Pharmacol       Date:  1993-03-09       Impact factor: 5.858

10.  Expression of mammalian glutathione S-transferase 5-5 in Salmonella typhimurium TA1535 leads to base-pair mutations upon exposure to dihalomethanes.

Authors:  R Thier; J B Taylor; S E Pemble; W G Humphreys; M Persmark; B Ketterer; F P Guengerich
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

View more
  19 in total

1.  PharmGKB summary: very important pharmacogene information for GSTT1.

Authors:  Caroline F Thorn; Yuan Ji; Richard M Weinshilboum; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-08       Impact factor: 2.089

2.  Genomic cloning and characterization of the rat glutathione S-transferase-A3-subunit gene.

Authors:  N Fotouhi-Ardakani; G Batist
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

3.  Residue 234 in glutathione transferase T1-1 plays a pivotal role in the catalytic activity and the selectivity against alternative substrates.

Authors:  Abeer Shokeer; Anna-Karin Larsson; Bengt Mannervik
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

4.  DNA polymerase I is essential for growth of Methylobacterium dichloromethanicum DM4 with dichloromethane.

Authors:  M F Kayser; M T Stumpp; S Vuilleumier
Journal:  J Bacteriol       Date:  2000-10       Impact factor: 3.490

5.  Purification from rat liver of a novel constitutively expressed member of the aldo-keto reductase 7 family that is widely distributed in extrahepatic tissues.

Authors:  V P Kelly; L S Ireland; E M Ellis; J D Hayes
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

6.  Epidermal growth factor regulation of glutathione S-transferase gene expression in the rat is mediated by class Pi glutathione S-transferase enhancer I.

Authors:  M Matsumoto; M Imagawa; Y Aoki
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

7.  Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology.

Authors:  P David Josephy
Journal:  Hum Genomics Proteomics       Date:  2010-06-13

Review 8.  Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease.

Authors:  Lauren E Tebay; Holly Robertson; Stephen T Durant; Steven R Vitale; Trevor M Penning; Albena T Dinkova-Kostova; John D Hayes
Journal:  Free Radic Biol Med       Date:  2015-06-27       Impact factor: 7.376

Review 9.  On enzyme-based anticancer molecular dietary manipulations.

Authors:  Andrea Sapone; Donatella Canistro; Simone Melega; Ramona Moles; Fabio Vivarelli; Moreno Paolini
Journal:  J Biomed Biotechnol       Date:  2012-09-20

10.  Gastrointestinal and hepatotoxicity assessment of an anticancer extract from muricid molluscs.

Authors:  Chantel B Westley; Kirsten Benkendorff; Cassandra M McIver; Richard K Le Leu; Catherine A Abbott
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-17       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.